A recent article (in German in Der Urologe) has discussed the early use of PSMA-radio-guided surgery (PSMA-RGS) for targeted resection of localized prostate cancer recurrence. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: identification, PSMA, radio-guidance, recurrence, surgery, tumor | 1 Comment »
This morning we have a series of four more prostate cancer-related summary reports from the 14th annual meeting of the Society for Urologic Oncology (SUO) available on the UroToday web site (which is freely accessible to patients, but you do have to register to access it). … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Uncategorized | Tagged: ctive surveilance, identification, patient, selection | 2 Comments »
According to a statement issued today by the U.S. Food and Drug Adminstration, the agency has approved a product called Lymphoseek (technetium Tc 99m tilmanocept) Injection, which is a radioactive imaging agent that helps doctors locate lymph nodes in patients with breast cancer or melanoma who are having surgery to remove tumor-draining lymph nodes. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Uncategorized | Tagged: identification, location, lymph, Lymphoseek, node, removal | Leave a comment »
One of the hardest things to be able to do, currently, in a man with progressive prostate cancer after first- or second-line therapy, is to determine his risk for lymph node-positive prostate cancer or LNPPC (i.e., one of the earliest and more common components of metastatic prostate cancer). … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: accuracy, identification, imaging, lymph node, positive, test | 5 Comments »
THE "NEW" PROSTATE CANCER INFOLINK 